• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Subtyping of influenza neuraminidase using mass spectrometry

tetano

Editor, Senior Moderator
Analyst. 2013 Feb 1. [Epub ahead of print]
Subtyping of influenza neuraminidase using mass spectrometry.
Nguyen AP, Downard KM.
Source

School of Molecular Bioscience, University of Sydney, Sydney, NSW 2006, Australia. k.downard@sydney.edu.au.
Abstract

A proteotyping approach which employs high resolution mass spectrometry is shown to be able to differentiate all nine neuraminidase subtypes of type A influenza viruses that infect both humans and animals. Conserved sequences among tryptic peptides were identified through alignments of influenza neuraminidase sequences across all subtypes N1-N9 among human and animal hosts. Those that were unique in mass represent signature peptides which, when detected in the mass spectra of an influenza neuraminidase or whole virus digest, enable strains to be subtyped with confidence. The ability to distinguish N1 neuraminidase derived from human H5N1 and H1N1 strains is also demonstrated. The approach provides a more rapid and direct approach with which to subtype the virus than conventional molecular based PCR methods with comparable sensitivity. This should help facilitate a more rapid response in the event of a local epidemic or global pandemic.

PMID:
23370118
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23370118
 
Back
Top Bottom